A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)

• Status: Withdrawn
• Trial end date: 2015-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This long-term study will follow patients with known or suspected of having coronary artery disease (CAD) and have participated in present and future BMS747158 clinical studies. The purpose of this study is to evaluate the long-term predictive value associated with BMS747158 Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lantheus Medical Imaging

Criteria

Inclusion Criteria:

• Have known or suspected CAD

• Have participated in a BMS747158 clinical study

• Have received at least 1 dose of BMS747158

• Provide signed informed consent for this study prior to any follow-up contact

• Be capable of communicating effectively with study personnel

Exclusion Criteria:

• If determined by the Investigator that participation in the study is not in the best interest of the patient or for any sound medical, psychiatric, and/or social reason.